The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Tumor microenvironment promotes breast cancer chemoresistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0307 · Cited by 5,913
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
TIMER2.0 for analysis of tumor-infiltrating immune cells
Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa407 · Cited by 5,209
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Li, B., Severson, E., Pignon, J.-C., Zhao, H., Li, T., Novak, J., Jiang, P., Shen, H., Aster, J. C., Rodig, S., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1028-7 · Cited by 2,451
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Ancient DNA and the rewriting of human history: be sparing with Occam’s razor
Haber, M., Mezzavilla, M., Xue, Y., & Tyler-Smith, C. (2016) · Genome Biology · doi:10.1186/s13059-015-0866-z · Cited by 1,924
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474 · cited 1×
“TAMs impact therapeutic outcomes by secreting survival factors and/or activating anti-apoptotic signaling pathways in tumor cells [33].”
BackgroundRole of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085
Baccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Ono, M., Kosaka, N., Tominaga, N., Yoshioka, Y., Takeshita, F., Takahashi, R.-U., Yoshida, M., Tsuda, H., Tamura, K., & Ochiya, T. (2014) · Science Signaling · doi:10.1126/scisignal.2005231 · Cited by 696
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
Ali, H. R., Chlon, L., Pharoah, P. D. P., Markowetz, F., & Caldas, C. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002194 · Cited by 615
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541 · cited 2×
“In mouse models and breast cancer tissue of patients, treated tumors with paclitaxel exhibited augmented intrusion of TAMs compared to non-treated tumors [49].”
BackgroundResultThe extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
Heterogeneity of the Tumor Vasculature
Nagy, J., Chang, S.-H., Shih, S.-C., Dvorak, A., & Dvorak, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253454 · Cited by 422
Human breast cancer cells educate macrophages toward the M2 activation status
Sousa, S., Brion, R., Lintunen, M., Kronqvist, P., Sandholm, J., Mönkkönen, J., Kellokumpu-Lehtinen, P.-L., Lauttia, S., Tynninen, O., Joensuu, H., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0621-0 · Cited by 415
Patel, S. A., Meyer, J. R., Greco, S. J., Corcoran, K. E., Bryan, M., & Rameshwar, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903143 · Cited by 363
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
Bartucci, M., Dattilo, R., Moriconi, C., Pagliuca, A., Mottolese, M., Federici, G., Benedetto, A. D., Todaro, M., Stassi, G., Sperati, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.5 · Cited by 350
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Lovitt, C. J., Shelper, T. B., & Avery, V. M. (2018) · BMC Cancer · doi:10.1186/s12885-017-3953-6 · Cited by 339
Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1
Zhu, Y., Sun, Z., Han, Q., Liao, L., Wang, J., Bian, C., Li, J., Yan, X., Liu, Y., Shao, C., et al. (2009) · Leukemia · doi:10.1038/leu.2008.384 · Cited by 338
Cancer stem cell in breast cancer therapeutic resistance
Bai, X., Ni, J., Beretov, J., Graham, P., & Li, Y. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.004 · Cited by 328
Exosome-mediated breast cancer chemoresistance via miR-155 transfer
Santos, J. C., Lima, N. D. S., Sarian, L. O., Matheu, A., Ribeiro, M. L., & Derchain, S. F. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19339-5 · Cited by 325
Endothelial Notch1 Activity Facilitates Metastasis
Wieland, E., Rodriguez-Vita, J., Liebler, S. S., Mogler, C., Moll, I., Herberich, S. E., Espinet, E., Herpel, E., Menuchin, A., Chang-Claude, J., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.007 · Cited by 314
Qiao, L., Xu, Z.-L., Zhao, T.-J., Ye, L.-H., & Zhang, X.-D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.032 · Cited by 313 · cited 1×
“In addition, co-culture studies demonstrated that MSCs inhibit tumor cell proliferation by secreted factors such as DKK-1, and knockdown of DKK-1 in MSCs reduced the antitumor effect of MSC [71, 72].”
BackgroundApicella, M., Giannoni, E., Fiore, S., Ferrari, K. J., Fernández-Pérez, D., Isella, C., Granchi, C., Minutolo, F., Sottile, A., Comoglio, P. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.006 · Cited by 299
Tumour-infiltrating macrophages and clinical outcome in breast cancer
Mahmoud, S. M. A., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200355 · Cited by 268
Zhang, T., Lee, Y. W., Rui, Y. F., Cheng, T. Y., Jiang, X. H., & Li, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt221 · Cited by 234
Tiainen, S., Tumelius, R., Rilla, K., Hämäläinen, K., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2015) · Histopathology · doi:10.1111/his.12607 · Cited by 234
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
Brechbuhl, H. M., Finlay-Schultz, J., Yamamoto, T. M., Gillen, A. E., Cittelly, D. M., Tan, A.-C., Sams, S. B., Pillai, M. M., Elias, A. D., Robinson, W. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2851 · Cited by 228
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
Sun, B., Roh, K.-H., Park, J.-R., Lee, S.-R., Park, S.-B., Jung, J.-W., Kang, S.-K., Lee, Y.-S., & Kang, K.-S. (2009) · Cytotherapy · doi:10.1080/14653240902807026 · Cited by 214 · cited 1×
“revealed that mesenchymal progenitor cells inhibit the growth of tumor cells in both in vitro and in vivo models [69, 70].”
BackgroundYuan, Z.-Y., Luo, R.-Z., Peng, R.-J., Wang, S.-S., & Xue, C. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s61838 · Cited by 214
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
Takai, K., Le, A., Weaver, V. M., & Werb, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12658 · Cited by 207
Yan, D., Wang, H.-W., Bowman, R. L., & Joyce, J. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.035 · Cited by 194
Yang, C., He, L., He, P., Liu, Y., Wang, W., He, Y., Du, Y., & Gao, F. (2015) · Medical Oncology · doi:10.1007/s12032-014-0352-6 · Cited by 189
Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K., & Lindvall, M. (2003) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.06.001 · Cited by 182
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.018 · Cited by 179
Martinez-Outschoorn, U. E., Goldberg, A. F., Lin, Z., Ko, Y.-H., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17780 · Cited by 174
Breast Cancer — Loss of PTEN Predicts Resistance to Treatment
Pandolfi, P. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmcibr043143 · Cited by 167
Tumor microenvironment for cancer stem cells
Kise, K., Kinugasa‐Katayama, Y., & Takakura, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.08.005 · Cited by 166
Pontiggia, O., Sampayo, R., Raffo, D., Motter, A., Xu, R., Bissell, M. J., de Kier Joffé, E. B., & Simian, M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166
Chan, T.-S., Hsu, C.-C., Pai, V. C., Liao, W.-Y., Huang, S.-S., Tan, K.-T., Yen, C.-J., Hsu, S.-C., Chen, W.-Y., Shan, Y.-S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151665 · Cited by 161
Lu, X., Cao, X., Zhu, Y., Wu, Z., Zhuang, X., Shao, M., Xu, Q., Zhou, Y., Ji, H., Lu, Q.-R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0428-x · Cited by 151
Joyce, M. H., Lu, C., James, E. R., Hegab, R. A., Allen, S. C., Suggs, L. J., & Brock, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00337 · Cited by 151
Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
Olson, O. C., Kim, H.-J., Quail, D. F., Foley, E. A., & Joyce, J. A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.038 · Cited by 150
Tumor microenvironment-mediated chemoresistance in breast cancer
Velaei, K., Samadi, N., Brazvan, B., & Rad, J. S. (2016) · The Breast · doi:10.1016/j.breast.2016.09.002 · Cited by 149
Mohammed, Z. M. A., Going, J. J., Edwards, J., Elsberger, B., Doughty, J., & McMillan, D. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.347 · Cited by 148
Sansone, P., Berishaj, M., Rajasekhar, V. K., Ceccarelli, C., Chang, Q., Strillacci, A., Savini, C., Shapiro, L., Bowman, R. L., Mastroleo, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2129 · Cited by 140
Biroccio, A., Candiloro, A., Mottolese, M., Sapora, O., Albini, A., Zupi, G., & Bufalo, D. D. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.652 · Cited by 139
Cao, Z., Scandura, J. M., Inghirami, G., Shido, K., Ding, B., & Rafii, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.010 · Cited by 138
Gwak, J. M., Jang, M. H., Kim, D. I., Seo, A. N., & Park, S. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125728 · Cited by 132
Zhang, W., Wang, X., Gao, S.-T., Chen, C., Xu, X., Sun, Q., Zhou, Z.-H., Wu, G.-Z., Yu, Q., Xu, G., et al. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.09.035 · Cited by 126
Insua‐Rodríguez, J., Pein, M., Hongu, T., Meier, J., Descot, A., Lowy, C., Braekeleer, E. D., Sinn, H., Spaich, S., Sütterlin, M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809003 · Cited by 123
Mueller, K. L., Madden, J. M., Zoratti, G. L., Kuperwasser, C., List, K., & Boerner, J. L. (2012) · Breast Cancer Research · doi:10.1186/bcr3224 · Cited by 122
Zhao, X., Lin, Y., Jiang, J., Tang, Z., Yang, S., Lu, L., Liang, Y., Liu, X., Tan, J., Hu, X., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4958 · Cited by 121
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours
Rafii, A., Mirshahi, P., Poupot, M., Faussat, A., Simon, A., Ducros, E., Mery-Lamarche, E., Couderc, B. C., Lis, R., Capdet, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003894 · Cited by 119
Xing, H., Weng, D., Chen, G., Tao, W., Zhu, T., Yang, X., Li, M., Wang, S., Lu, Y., & Ma, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.022 · Cited by 116
Metabolic reprogramming of the tumour microenvironment
Xing, Y., Zhao, S., Zhou, B. P., & Mi, J. (2015) · The FEBS Journal · doi:10.1111/febs.13402 · Cited by 108
Clarke, M. R., Imhoff, F. M., & Baird, S. K. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22178 · Cited by 108
Sun, Y., Fan, X., Zhang, Q. H., Shi, X., Xu, G., & Zou, C. (2017) · Tumor Biology · doi:10.1177/1010428317712592 · Cited by 104
Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
Virrey, J. J., Guan, S., Li, W., Schönthal, A. H., Chen, T. C., & Hofman, F. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071079 · Cited by 96
Cell Adhesion to Fibronectin (CAM-DR) Influences Acquired Mitoxantrone Resistance in U937 Cells
Hazlehurst, L., Argilagos, R. F., Emmons, M. F., Boulware, D. C., Beam, C. A., Sullivan, D. M., & Dalton, W. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3256 · Cited by 93
Park, S. Y., Kim, H. M., & Koo, J. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3291-9 · Cited by 90
Alavi, A., Acevedo, L. M., Wang, M., & Cheresh, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3648 · Cited by 88
Miklikova, S., Matúšková, M., Boháč, M., Toro, L., Durinikova, E., Tyčiaková, S., Demková, L., Gurský, J., & Kučerová, L. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0127-0 · Cited by 88
Ghiabi, P., Jiang, J., Pasquier, J., Maleki, M., Abu-Kaoud, N., Rafii, S., & Rafii, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112424 · Cited by 82
Shee, K., Yang, W., Hinds, J. W., Hampsch, R. A., Varn, F. S., Traphagen, N. A., Patel, K., Cheng, C., Jenkins, N. P., Kettenbach, A. N., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171818 · Cited by 81
Emerging therapies for breast cancer
Hu, X., Huang, W., & Fan, M. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0466-3 · Cited by 77
Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
Ryoo, I.-G., Choi, B.-H., & Kwak, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3047 · Cited by 75
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Huelsken, J., & Hanahan, D. (2018) · Cell · doi:10.1016/j.cell.2018.01.028 · Cited by 72
Kim, H. M., Jung, W. H., & Koo, J. S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0587-9 · Cited by 71
Verigos, J., Karakaidos, P., Kordias, D., Papoudou‐Bai, A., Evangelou, Z., Harissis, H. V., Klinakis, A., & Magklara, A. (2019) · Cancers · doi:10.3390/cancers11101585 · Cited by 71
Bahrami, A., Hassanian, S. M., Khazaei, M., Hasanzadeh, M., Shahidsales, S., Maftouh, M., Ferns, G. A., & Avan, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26183 · Cited by 68
Klingen, T. A., Chen, Y., Aas, H., Wik, E., & Akslen, L. A. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.09.001 · Cited by 67
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism
Ullah, M., Akbar, A., Ng, N. N., Concepcion, W., & Thakor, A. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26952 · Cited by 62
Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells
Mao, Y., Zhang, Y., Qu, Q., Zhao, M., Lou, Y., Liu, J., Huang, O., Chen, X., Wu, J., & Shen, K. (2015) · Molecular BioSystems · doi:10.1039/c4mb00710g · Cited by 54
Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis
Mir, M. A., & Mehraj, U. (2019) · Current Immunology Reviews · doi:10.2174/1573395515666190611122818 · Cited by 54
Self-citationDaverey, A., Drain, A. P., & Kidambi, S. (2015) · Scientific Reports · doi:10.1038/srep13744 · Cited by 51
Houthuijzen, J. M., Daenen, L. G. M., Roodhart, J. M. L., Oosterom, I., van Jaarsveld, M. T. M., Govaert, K. M., Smith, M. E., Sadatmand, S. J., Rosing, H., Kruse, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6275 · Cited by 51
Tumor resident mesenchymal stromal cells endow naïve stromal cells with tumor-promoting properties
Ren, G., Liu, Y. F., Zhao, X., Zhang, J. J., Zheng, B., Yuan, Z.-R., Zhang, L., Qu, X., Tischfield, J. A., Shao, C., et al. (2013) · Oncogene · doi:10.1038/onc.2013.387 · Cited by 49
Zhu, L., Gao, J., Hu, Z., Schwab, C. L., Zhuang, H., Tan, M., Yan, L., Liu, J., Zhang, D., & Lin, B. (2015) · Europe PMC (PubMed Central) · Cited by 40
ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
Leccia, F., Vecchio, L. D., Mariotti, E., Noto, R. D., Morel, A., Puisieux, A., Salvatore, F., & Ansieau, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-213 · Cited by 38
Michaelis, M., Klassert, D., Barth, S., Suhan, T. O., Breitling, R., Mayer, B., Hinsch, N., Doerr, H. W., Činátl, J., & Cinatl, J. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-80 · Cited by 35
Usman, M. W., Gao, J., Zheng, T., Rui, C., Li, T., Bian, X., Cheng, H.-L. M., Liu, P., & Luo, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0849-6 · Cited by 34
Malfuson, J.-V., Boutin, L., Clay, D., Thépenier, C., Desterke, C., Torossian, F., Guerton, B., Anginot, A., de Revel, T., Lataillade, J.-J., et al. (2013) · Leukemia · doi:10.1038/leu.2013.256 · Cited by 30
Ueno, T., Utsumi, J., Toi, M., & Shimizu, K. (2015) · BioMed Research International · doi:10.1155/2015/960840 · Cited by 24
Liu, H., Wang, J., Liu, Z., Wang, L., Liu, S., & Zhang, Q. (2017) · Medicine · doi:10.1097/md.0000000000006663 · Cited by 23
The role of cancer-associated fibroblasts in breast cancer pathobiology.
Jung, Y. Y., Kim, H. M., & Koo, J. S. (2016) · PubMed · doi:10.14670/hh-11-700 · Cited by 21
Cited by
Major pathways involved in macrophage polarization in cancer
Kerneur, C., Cano, C. E., & Olive, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026954 · Cited by 337
Metadata
- Authors
- Mehraj, U., Dar, A. H., Wani, N. A., & Mir, M. A.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2021-01-09
- Volume
- 87
- Issue
- 2
- Pages
- 147-158
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W3118345283
- Cited by
- 289
- References
- 107
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.